Report Detail
Global Brentuximub Vedoti Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
- RnM2776987 |
- 17 January, 2019 |
- Global |
- 105 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Brentuximab vedotin is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL). It selectively targets tumor cells expressing the CD30 antigen, a defining marker of Hodgkin lymphoma and ALCL (a type of T cell non-Hodgkin lymphoma).
Scope of the Report:
The worldwide market for Brentuximub Vedoti is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Brentuximub Vedoti in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Seattle Genetics
Takada
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Podwer
Liquid
Market Segment by Applications, can be divided into
Hospital
Drugs Store
Other
There are 15 Chapters to deeply display the global Brentuximub Vedoti market.
Chapter 1, to describe Brentuximub Vedoti Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Brentuximub Vedoti, with sales, revenue, and price of Brentuximub Vedoti, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Brentuximub Vedoti, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Brentuximub Vedoti market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Brentuximub Vedoti sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents
1 Market Overview
- 1.1 Brentuximub Vedoti Introduction
- 1.2 Market Analysis by Type
- 1.2.1 Podwer
- 1.2.2 Liquid
- 1.3 Market Analysis by Applications
- 1.3.1 Hospital
- 1.3.2 Drugs Store
- 1.3.3 Other
- 1.4 Market Analysis by Regions
- 1.4.1 North America (United States, Canada and Mexico)
- 1.4.1.1 United States Market States and Outlook (2013-2023)
- 1.4.1.2 Canada Market States and Outlook (2013-2023)
- 1.4.1.3 Mexico Market States and Outlook (2013-2023)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy)
- 1.4.2.1 Germany Market States and Outlook (2013-2023)
- 1.4.2.2 France Market States and Outlook (2013-2023)
- 1.4.2.3 UK Market States and Outlook (2013-2023)
- 1.4.2.4 Russia Market States and Outlook (2013-2023)
- 1.4.2.5 Italy Market States and Outlook (2013-2023)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- 1.4.3.1 China Market States and Outlook (2013-2023)
- 1.4.3.2 Japan Market States and Outlook (2013-2023)
- 1.4.3.3 Korea Market States and Outlook (2013-2023)
- 1.4.3.4 India Market States and Outlook (2013-2023)
- 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
- 1.4.4 South America, Middle East and Africa
- 1.4.4.1 Brazil Market States and Outlook (2013-2023)
- 1.4.4.2 Egypt Market States and Outlook (2013-2023)
- 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
- 1.4.4.4 South Africa Market States and Outlook (2013-2023)
- 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
- 1.4.1 North America (United States, Canada and Mexico)
- 1.5 Market Dynamics
- 1.5.1 Market Opportunities
- 1.5.2 Market Risk
- 1.5.3 Market Driving Force
2 Manufacturers Profiles
- 2.1 Seattle Genetics
- 2.1.1 Business Overview
- 2.1.2 Brentuximub Vedoti Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Seattle Genetics Brentuximub Vedoti Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
- 2.2 Takada
- 2.2.1 Business Overview
- 2.2.2 Brentuximub Vedoti Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 Takada Brentuximub Vedoti Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Brentuximub Vedoti Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
- 3.1 Global Brentuximub Vedoti Sales and Market Share by Manufacturer (2016-2017)
- 3.2 Global Brentuximub Vedoti Revenue and Market Share by Manufacturer (2016-2017)
- 3.3 Market Concentration Rate
- 3.3.1 Top 3 Brentuximub Vedoti Manufacturer Market Share in 2017
- 3.3.2 Top 6 Brentuximub Vedoti Manufacturer Market Share in 2017
- 3.4 Market Competition Trend
4 Global Brentuximub Vedoti Market Analysis by Regions
- 4.1 Global Brentuximub Vedoti Sales, Revenue and Market Share by Regions
- 4.1.1 Global Brentuximub Vedoti Sales and Market Share by Regions (2013-2018)
- 4.1.2 Global Brentuximub Vedoti Revenue and Market Share by Regions (2013-2018)
- 4.2 North America Brentuximub Vedoti Sales and Growth Rate (2013-2018)
- 4.3 Europe Brentuximub Vedoti Sales and Growth Rate (2013-2018)
- 4.4 Asia-Pacific Brentuximub Vedoti Sales and Growth Rate (2013-2018)
- 4.5 South America Brentuximub Vedoti Sales and Growth Rate (2013-2018)
- 4.6 Middle East and Africa Brentuximub Vedoti Sales and Growth Rate (2013-2018)
5 North America Brentuximub Vedoti by Countries
- 5.1 North America Brentuximub Vedoti Sales, Revenue and Market Share by Countries
- 5.1.1 North America Brentuximub Vedoti Sales and Market Share by Countries (2013-2018)
- 5.1.2 North America Brentuximub Vedoti Revenue and Market Share by Countries (2013-2018)
- 5.2 United States Brentuximub Vedoti Sales and Growth Rate (2013-2018)
- 5.3 Canada Brentuximub Vedoti Sales and Growth Rate (2013-2018)
- 5.4 Mexico Brentuximub Vedoti Sales and Growth Rate (2013-2018)
6 Europe Brentuximub Vedoti by Countries
- 6.1 Europe Brentuximub Vedoti Sales, Revenue and Market Share by Countries
- 6.1.1 Europe Brentuximub Vedoti Sales and Market Share by Countries (2013-2018)
- 6.1.2 Europe Brentuximub Vedoti Revenue and Market Share by Countries (2013-2018)
- 6.2 Germany Brentuximub Vedoti Sales and Growth Rate (2013-2018)
- 6.3 UK Brentuximub Vedoti Sales and Growth Rate (2013-2018)
- 6.4 France Brentuximub Vedoti Sales and Growth Rate (2013-2018)
- 6.5 Russia Brentuximub Vedoti Sales and Growth Rate (2013-2018)
- 6.6 Italy Brentuximub Vedoti Sales and Growth Rate (2013-2018)
7 Asia-Pacific Brentuximub Vedoti by Countries
- 7.1 Asia-Pacific Brentuximub Vedoti Sales, Revenue and Market Share by Countries
- 7.1.1 Asia-Pacific Brentuximub Vedoti Sales and Market Share by Countries (2013-2018)
- 7.1.2 Asia-Pacific Brentuximub Vedoti Revenue and Market Share by Countries (2013-2018)
- 7.2 China Brentuximub Vedoti Sales and Growth Rate (2013-2018)
- 7.3 Japan Brentuximub Vedoti Sales and Growth Rate (2013-2018)
- 7.4 Korea Brentuximub Vedoti Sales and Growth Rate (2013-2018)
- 7.5 India Brentuximub Vedoti Sales and Growth Rate (2013-2018)
- 7.6 Southeast Asia Brentuximub Vedoti Sales and Growth Rate (2013-2018)
8 South America Brentuximub Vedoti by Countries
- 8.1 South America Brentuximub Vedoti Sales, Revenue and Market Share by Countries
- 8.1.1 South America Brentuximub Vedoti Sales and Market Share by Countries (2013-2018)
- 8.1.2 South America Brentuximub Vedoti Revenue and Market Share by Countries (2013-2018)
- 8.2 Brazil Brentuximub Vedoti Sales and Growth Rate (2013-2018)
- 8.3 Argentina Brentuximub Vedoti Sales and Growth Rate (2013-2018)
- 8.4 Colombia Brentuximub Vedoti Sales and Growth Rate (2013-2018)
9 Middle East and Africa Brentuximub Vedoti by Countries
- 9.1 Middle East and Africa Brentuximub Vedoti Sales, Revenue and Market Share by Countries
- 9.1.1 Middle East and Africa Brentuximub Vedoti Sales and Market Share by Countries (2013-2018)
- 9.1.2 Middle East and Africa Brentuximub Vedoti Revenue and Market Share by Countries (2013-2018)
- 9.2 Saudi Arabia Brentuximub Vedoti Sales and Growth Rate (2013-2018)
- 9.3 UAE Brentuximub Vedoti Sales and Growth Rate (2013-2018)
- 9.4 Egypt Brentuximub Vedoti Sales and Growth Rate (2013-2018)
- 9.5 Nigeria Brentuximub Vedoti Sales and Growth Rate (2013-2018)
- 9.6 South Africa Brentuximub Vedoti Sales and Growth Rate (2013-2018)
10 Global Brentuximub Vedoti Market Segment by Type
- 10.1 Global Brentuximub Vedoti Sales, Revenue and Market Share by Type (2013-2018)
- 10.1.1 Global Brentuximub Vedoti Sales and Market Share by Type (2013-2018)
- 10.1.2 Global Brentuximub Vedoti Revenue and Market Share by Type (2013-2018)
- 10.2 Podwer Sales Growth and Price
- 10.2.1 Global Podwer Sales Growth (2013-2018)
- 10.2.2 Global Podwer Price (2013-2018)
- 10.3 Liquid Sales Growth and Price
- 10.3.1 Global Liquid Sales Growth (2013-2018)
- 10.3.2 Global Liquid Price (2013-2018)
11 Global Brentuximub Vedoti Market Segment by Application
- 11.1 Global Brentuximub Vedoti Sales Market Share by Application (2013-2018)
- 11.2 Hospital Sales Growth (2013-2018)
- 11.3 Drugs Store Sales Growth (2013-2018)
- 11.4 Other Sales Growth (2013-2018)
12 Brentuximub Vedoti Market Forecast (2018-2023)
- 12.1 Global Brentuximub Vedoti Sales, Revenue and Growth Rate (2018-2023)
- 12.2 Brentuximub Vedoti Market Forecast by Regions (2018-2023)
- 12.2.1 North America Brentuximub Vedoti Market Forecast (2018-2023)
- 12.2.2 Europe Brentuximub Vedoti Market Forecast (2018-2023)
- 12.2.3 Asia-Pacific Brentuximub Vedoti Market Forecast (2018-2023)
- 12.2.4 South America Brentuximub Vedoti Market Forecast (2018-2023)
- 12.2.5 Middle East and Africa Brentuximub Vedoti Market Forecast (2018-2023)
- 12.3 Brentuximub Vedoti Market Forecast by Type (2018-2023)
- 12.3.1 Global Brentuximub Vedoti Sales Forecast by Type (2018-2023)
- 12.3.2 Global Brentuximub Vedoti Market Share Forecast by Type (2018-2023)
- 12.4 Brentuximub Vedoti Market Forecast by Application (2018-2023)
- 12.4.1 Global Brentuximub Vedoti Sales Forecast by Application (2018-2023)
- 12.4.2 Global Brentuximub Vedoti Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
- 13.1 Sales Channel
- 13.1.1 Direct Marketing
- 13.1.2 Indirect Marketing
- 13.1.3 Marketing Channel Future Trend
- 13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
- 15.1 Methodology
Summary:
Get latest Market Research Reports on Brentuximub Vedoti . Industry analysis & Market Report on Brentuximub Vedoti is a syndicated market report, published as Global Brentuximub Vedoti Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Brentuximub Vedoti market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
